34.40
0.00
(0.00%)
At close: March 3 at 4:43:32 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 9 | 9 |
| Avg. Estimate | -- | -- | 26.46M | 185.7M |
| Low Estimate | -- | -- | -- | 7M |
| High Estimate | -- | -- | 175M | 568M |
| Year Ago Sales | -- | -- | -- | 26.46M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 601.73% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2QK.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/26/2024 |
| Maintains | Wedbush: Outperform to Outperform | 11/25/2024 |
| Maintains | Truist Securities: Buy to Buy | 11/25/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/12/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 10/15/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 10/14/2024 |
Related Tickers
8AP.SG Agios Pharmaceuticals Inc
31.40
-4.27%
ISI.MU Ionis Pharmaceuticals Inc
31.83
+4.74%
ISI.F Ionis Pharmaceuticals, Inc.
31.80
+6.21%
1AEA.HA argenx SE
595.00
+0.85%
1AE.SG argenx SE
607.00
+3.51%
1AE.F argenx SE
600.20
+1.73%
VX1.F Vertex Pharmaceuticals Incorporated
466.05
+0.17%
BHVN Biohaven Ltd.
32.06
-13.77%
RVMD Revolution Medicines, Inc.
38.34
-5.89%
INCY Incyte Corporation
70.26
-4.41%